Cystinuria is an inherited metabolic disorder characterized by the abnormal movement (transport) in the intestines and kidneys, of certain organic chemical compounds (amino acids). These include cystine, lysine, arginine, and ornithine. Excessive amounts of undissolved cysteine in the urine (cystinuria) cause the formation of stones (calculi) in the kidney, bladder, or ureter.
DelveInsight’s ‘Cystinuria Market Insight, Epidemiology and Market Forecast – 2030′ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of Cystinuria in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom), and Japan. The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, the current and forecasted market size of Cystinuria from 2018 to 2030 segmented by seven major markets.
Some Key Facts of Cystinuria Market:
Request for Free Sample Request: https://www.delveinsight.com/sample-request/cystinuria-market-insights
Key benefits of the Cystinuria Market Report:
“Cystinuria as a cause of 1–2% of stones observed in adults and about 10% of those occurring in children.”
The primary objective of Cystinuria treatment is to reduce the cystine concentration in the urine. The foremost aim of cystinuria treatment is to prevent the formation of the stone. The first line of treatment is high-fluid intake, which prevents the formation of new stones and dissolves the previously formed ones. By increasing the volume of urine, the concentration of cystine in the urine is reduced which prevents cystine from precipitating from the urine and forming stones.
Another strategy that has been attempted for cystinuria treatment is alkalization of the urine. The rationale is that in an alkaline (nonacidic) liquid, cystine tends to stay in solution and there it does no harm. Another approach for cystinuria treatment is the administration of D-penicillamine. D-penicillamine promotes the formation of cystine in a different chemical form (mixed disulfide), which is more soluble in the urine and is excreted easily.
Cystinuria Therapies are:
Cystinuria Companies Covered:
Table of contents
1. Key Insights
2. Executive Summary of Cystinuria
3. Competitive Intelligence Analysis for Cystinuria
4. Cystinuria : Market Overview at a Glance
5. Cystinuria : Disease Background and Overview
6. Patient Journey
7. Cystinuria Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Cystinuria Treatment
11. Marketed Products
12. Emerging Therapies
13. Cystinuria: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Cystinuria
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life science. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/cystinuria-market-insights